U.S. Stocks Trade Higher; Producer Prices Unexpectedly Decline In July
U.S. stocks traded higher this morning, following the release of PPI data.
Dow Drops Over 100 Points; Verona Pharma Shares Jump
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Recap: Comstock Res Q2 Earnings
Comstock Res (NYSE:CRK) reported its Q2 earnings results on Monday, August 1, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Comstock Res beat estimated earnings by 9.89%, reporting an EPS of $1.0 versus an estimate of $0.91.
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell
• Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Piper Sandler Upgrades Comstock Res to Neutral, Raises Price Target to $17
Piper Sandler analyst Kashy Harrison upgrades Comstock Res (NYSE:CRK) from Underweight to Neutral and raises the price target from $16 to $17.
Fading The Rip Higher: A Hedged Bet Against Technology Stocks After Tuesday’s Bounce
Not Buying The Bounce
Stocks ripped higher Tuesday, despite all the familiar macro headwinds remaining in place: record inflation, rising interest rates, pending profit downgrades, the ongoing Ukraine War, plus added tensions with China.